アレルギー免疫療法市場規模、シェア、成長分析、治療タイプ別、アレルギータイプ別、流通チャネル別、地域別 - 産業予測、2024～2031年

アレルギー免疫療法の世界市場規模は2022年に20億7,000万米ドルとなり、予測期間（2024～2031年）のCAGRは9.0%で、2023年の22億6,000万米ドルから2031年には45億米ドルに成長する見通しです。

世界のアレルギー免疫療法市場は、治療方法、アレルギーの種類、流通チャネル、地域別に分類されています。治療法には、錠剤や点滴による皮下免疫療法（SCIT）や舌下免疫療法（SLIT）があり、アレルギー疾患にはアレルギー性鼻炎、アレルギー性喘息などが含まれます。流通はオンラインプラットフォームと病院や小売薬局などのオフラインの場を通じて行われ、市場は北米、欧州、アジア太平洋、中東・アフリカ、ラテンアメリカにまたがります。世界人口の10～30％が様々なアレルギーに罹患していると推定される中、免疫療法の需要は拡大しています。市場拡大の要因としては、産業の成長、ヘルスケアの進歩、経口溶解錠のような革新的製品の規制当局による承認に後押しされた新しい治療法の導入などが挙げられます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩

アレルギー免疫療法市場規模：治療タイプ別およびCAGR（2024～2031年）

• 市場概要
• 皮下免疫療法
• 舌下免疫療法

アレルギー免疫療法市場規模：タイプ別およびCAGR（2024～2031年）

• 市場概要
• タブレット
• ドロップ

アレルギー免疫療法市場規模：アレルギータイプ別およびCAGR（2024～2031年）

• 市場概要
• アレルギー性鼻炎
• アレルギー性喘息
• その他

アレルギー免疫療法市場規模：流通チャネル別およびCAGR（2024～2031年）

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局

アレルギー免疫療法市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• ALK-Abello
• Allergy Therapeutics
• Anergis SA
• ASIT biotech
• DBV Technologies
• HAL Allergy Group
• Hymenoptera Immunotherapy Group
• Immunomic Therapeutics, Inc.
• Laboratorios LETI
• Merck KGaA
• Novartis International AG
• Stallergenes Greer plc
• Tunitas Therapeutics, Inc.
• VentiRx Pharmaceuticals
• Biomay AG
• Genentech, Inc.
• GlaxoSmithKline plc
• Meda AB
• Pfizer Inc.
• Regeneron Pharmaceuticals, Inc.

結論と推奨事項

Global Allergy Immunotherapy Market size was valued at USD 2.07 billion in 2022 and is poised to grow from USD 2.26 billion in 2023 to USD 4.5 billion by 2031, growing at a CAGR of 9.0% during the forecast period (2024-2031).

The global Allergy Immunotherapy Market is categorized by treatment methods, types of allergies, distribution channels, and geographical regions. Treatment options include Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT) through tablets and drops, while allergic conditions encompass allergic rhinitis, allergic asthma, and others. Distribution occurs through online platforms and offline venues, including hospital and retail pharmacies, and the market spans North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. With an estimated 10-30% of the global population affected by various allergies, the demand for immunotherapy is growing. Factors driving market expansion include industrial growth, advancements in healthcare, and the introduction of new therapies, bolstered by regulatory approvals for innovative products like oral dissolvable tablets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Immunotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Immunotherapy Market Segmental Analysis

Global Allergy Immunotherapy Market is segmented by treatment type, type, allergy type, distribution channel and region. Based on treatment type, the market is segmented into subcutaneous immunotherapy and sublingual immunotherapy. Based on type, the market is segmented into tablets and drops. Based on allergy type, the market is segmented into allergic rhinitis, allergic asthma and others. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Allergy Immunotherapy Market

The Global Allergy Immunotherapy market is primarily driven by the escalating incidence of allergies, which has created a pressing need for effective treatment options. The increasing cases of various allergies, along with the advent of novel sublingual immunotherapies, particularly in developing countries, are significantly propelling market growth. In the U.S., allergies rank as the sixth most prevalent chronic condition, impacting over 50 million individuals and incurring annual costs exceeding USD 18 billion, according to the American College of Allergy, Asthma & Immunology. Furthermore, the rising prevalence of food allergies among both children and adults worldwide is anticipated to further boost the demand for advanced immunotherapy solutions.

Restraints in the Global Allergy Immunotherapy Market

The global allergy immunotherapy market faces significant challenges due to several restraints. Primarily, the cutting-edge technology employed in allergy immunotherapy necessitates regular maintenance, which demands specialized professional expertise, thereby driving up routine maintenance costs. As a result, operational expenses are expected to increase, posing a substantial hurdle to market growth. Furthermore, there is a pressing need to enhance awareness and understanding of this advanced therapeutic approach across various sectors. The lack of familiarity with innovative technological advancements may act as an additional barrier to the market's development, hindering its potential expansion and limiting patient access to effective treatments.

Market Trends of the Global Allergy Immunotherapy Market

The Global Allergy Immunotherapy market is witnessing a significant upward trend driven by advancements in technology, particularly in high-resolution analysis of rare cells within local tissues. These innovations have facilitated the identification of precise and reliable biomarkers for monitoring allergy immunotherapy, enhancing treatment efficacy and personalizing patient care. As healthcare providers increasingly adopt these cutting-edge analytical techniques, the market is expected to expand rapidly, fostering the development of targeted therapies and improving patient compliance. Additionally, the growing prevalence of allergic conditions and rising awareness regarding effective treatment options further bolster market growth, positioning allergy immunotherapy as a vital component of modern allergy management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Allergy Immunotherapy Market Size by Treatment Type & CAGR (2024-2031)

• Market Overview
• Subcutaneous Immunotherapy
• Sublingual Immunotherapy

Global Allergy Immunotherapy Market Size by Type & CAGR (2024-2031)

• Market Overview
• Tablets
• Drops

Global Allergy Immunotherapy Market Size by Allergy Type & CAGR (2024-2031)

• Market Overview
• Allergic Rhinitis
• Allergic Asthma
• Others

Global Allergy Immunotherapy Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Allergy Immunotherapy Market Size & CAGR (2024-2031)

• North America (Treatment Type, Type, Allergy Type, Distribution Channel)
  • USA
  • Canada
• Europe (Treatment Type, Type, Allergy Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Type, Allergy Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Type, Allergy Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Type, Allergy Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• ALK-Abello
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergy Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anergis SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ASIT biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DBV Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HAL Allergy Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hymenoptera Immunotherapy Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immunomic Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratorios LETI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tunitas Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VentiRx Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomay AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meda AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations